| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |